Inhibikase Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.05 | $-0.04 |
| FY2022 | $-0.27 | $-0.12 |
| FY2023 | $-0.20 | $-0.14 |
| FY2024 | $-0.29 | $-0.17 |
| FY2025 | $-0.49 | $-0.23 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.05 | $-0.04 |
| FY2022 | $-0.27 | $-0.12 |
| FY2023 | $-0.20 | $-0.14 |
| FY2024 | $-0.29 | $-0.17 |
| FY2025 | $-0.49 | $-0.23 |